Industry: Pharmaceuticals, Biotechnology
Oxford BioMedica (LSE: OXB) is a biopharmaceutical company specialising in the development of novel gene-based therapeutics with a focus on oncology and neurotherapy. The Company was established in 1995 as a spin out from Oxford University, and is listed on the London Stock Exchange. Oxford BioMedica has core expertise in gene delivery, as well as in-house clinical, regulatory and manufacturing know-how. In oncology, the pipeline includes two clinical candidates and a preclinical targeted antibody therapy, which is being developed in collaboration with Wyeth. The Company has started Phase III development of its lead cancer immunotherapy product, TroVax, in renal cancer and has an ongoing Phase II programme in various cancer settings including renal, colorectal and prostate ( www.oxfordbiomedica.co.uk )
Oxford BioMedica plc
The Medawar Centre
Oxford, OXON Ox4 4ga
United Kingdom
Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
OSI Pharmaceuticals is committed to “shaping medicine and changing lives” by discovering, developing and commercializing high-quality and novel pharmaceutical products that extend life or improve the quality of life for patients with cancer, eye diseases and diabetes. The driving force behind OSI’s endeavors is the Company’s seasoned, multi-disciplined and dedicated team of approximately 500 research and development, regulatory, sales, marketing, commercial and business professionals. Performance has been and will continue to be the key to OSI’s success. Through its three business teams – (OSI) Oncology, (OSI) Eyetech and (OSI) Prosidion, the Company currently markets three FDA-approved drugs, including Tarceva® ( www.osip.com )
OSI Pharmaceuticals , Inc.
Suite 110 58 South Service Road
Melville, New York 11747
USA
Tel: (631) 962-2000
Fax: (631) 752-3880
Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Centocor, Inc. is a leading biopharmaceutical company that creates, acquires, and markets cost-effective therapies that yield long-term benefits for patients and the healthcare community. The company is dedicated to the research and development of treatments for a wide range of diseases including cancer, infectious diseases, cardiovascular and metabolic diseases and immune-mediated inflammatory disorders (I.M.I.D.), such as arthritis and inflammatory skin diseases. Centocor’s products, developed primarily through monoclonal antibody technology, help physicians deliver innovative treatments to improve human health and restore patients’ quality of life. Centocor is a wholly owned subsidiary of Johnson & Johnson, the worldwide manufacturer of healthcare products. ( www.centocor.com )
Centocor , Inc.
800 Ridgeview Drive
Horsham, Pennsylvania 19044
USA
Tel: (610) 651-6000
Fax: (610) 651-6100
Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Aventis Pasteur, the vaccines business of Aventis, in 2002, produced 1.4 billion doses of vaccine, making it possible to protect 500 million people across the globe, which is about 1.4 million per day. The company offers the broadest range of vaccines, providing protection against 20 bacterial and viral diseases. ( www.aventispasteur.com )
Aventis-Pasteur , Inc.
1755 Steeles Avenue West
Toronto, Ontario M2R 3T4
Canada
Tel: (416) 667-2955
Fax: (416) 667-2900
Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
CYBRDI is the pioneer and primary provider of tissue array products. CYBRDI has established a comprehensive and integrated system to collect various normal and diseased human tissues, and continuing throughout the manufacturing process of hundreds of tissue microarrays. By offering various high-quality tissue arrays in a format of single, paired, combined and multiple panels, CYBRDI enables scientists to identify, verify and validate molecules of diagnostic and therapeutic importance. Together with DNA (gene) array technique, tissue microarray technology is a powerful tool for the rapid analysis of molecular targets, discovery and assessment of new therapeutics, and determining prognosis of a disease. ( www.cybrdi.com )
Cybrdi , Inc.
401 Rosemont Ave, Fitci
Frederick, Maryland 21701
USA
Tel: (301) 644-3901
Fax: (240) 465-8877
Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Network Immunology Inc. is a vaccine company. The company’s focus is to commercialize a preventive HIV vaccine invented in 2005 by Dr. Geoffrey W. Hoffmann, the Chief Scientist of the company. The Network Immunology vaccine is for HIV negative persons. The technology is based on a theory of AIDS pathogenesis developed by Dr. Hoffmann (G. W. Hoffmann (1994) Co-selection in immune network theory and in AIDS pathogenesis, Immunology and Cell Biology, 72, 338-346). A key postulate of the theory was validated in a paper published eight years later (D. C. Douek et al. (2002) HIV preferentially infects HIV-specific CD4+ T cells. Nature, 417, 95-98). The global demand for an HIV/AIDS vaccine ia ( www.networkimmunologyinc.com )
Network Immunology Inc.
200 – 2386 East Mall #6
Vancouver, British Columbia V6T 1Z3
Canada
Tel: (604) 222-3605
Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
21st Century Biochemicals was founded by Dr. Jordan B. Fishman along with a team of talented scientists. Dr. Fishman received a dual Ph.D. in Biochemistry and Carcinogenesis/Toxicology in 1984 from the Oak Ridge Graduate School of Biomedical Sciences at Oak Ridge National Laboratory, an affiliate of the University of Tennessee. His postdoctoral work with Dr. Richard Fine was followed by his appointment as an Assistant Professor of Biochemistry at Boston University Medical Center. In 1988, Dr. Fishman joined the Department of Pharmacology at the University of Massachusetts Medical School, in Worcester, MA. ( www.21stcenturybio.com )
21st Century Biochemicals , LLC
33 Locke Drive
Marlboro, Massachusetts 01752
USA
Tel: (508) 303-8222
Fax: (508) 303-8333
Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Etubics Corporation is a biopharmaceutical company that is developing “next generation” vector vaccines for protection and therapeutic uses. The Company’s products will expand the armamentarium of the medical community for prevention and treatment of existing and emerging infectious diseases, as well as for the treatment of patients with chronic illness. Healthcare givers will use the products produced by the Company, in concert with other technology and techniques, to prevent and control outbreaks such as influenza, HIV, herpes simplex virus, hepatitis C virus and tuberculosis. The Company’s broad, versatile technology has been researched in the scientific laboratory for over ten ( www.etubics.com )
Etubics Corporation
Seattle Life Sciences Center 1124 Columbia Street, Suite 718
Seattle, Washington 98104
USA
Tel: (206) 818-2985
Fax: (509) 962-4040
Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
To further develop Evotope’s platform technology to identify and modulate cryptic allosteric regulatory sites on validated drug discovery target surfaces. Evotope Biosciences, Inc. was founded to address the fundamental unmet need of bio-pharmaceutical drug discovery, i.e., the identification of cryptic allosteric regulatory sites on protein surfaces. This is achieved through Evotope’s proprietary platform technology. Presently, bio-pharmaceutical drug discovery tools are restricted to the only knowable regions to which the tools can be applied, i.e, the active site / druggable site / hot spot of a protein ( www.evotope.com )
Evotope Biosciences Inc
25 East Loop Road
Stony Brook, New York 11790-3350
USA
Tel: (631) 444-6404
Fax: (631) 444-6899
Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
VPI is committed to becoming a world leader in the select pathogen detection and vaccination markets as well as providing a superior first responder solution for biodefense. Please visit our Research and Development page for more details. Some of our clients include: · Brooks Air Force Base · University of Louisville · US Army Edgewood Chemical and Biological Center · FOCUS Technologies · Replidyne, Inc. Vital Probes Officers ( www.vitalprobes.com )
Vital Probes Inc
1300 Old Plank Road
Mayfield, Pennsylvania 18433
USA
Tel: (570) 281-2502